Roche To Change Names, Cut Prices Of Herceptin, Mabthera In India
This article was originally published in PharmAsia News
Executive Summary
Roche plans to cut the India price of two of its costly cancer drugs while emphasizing the move is not to be interpreted as a signal of its plans for other drugs or other nations.